Clinical Trials Browser

Phase 1 × Brain Neoplasms × Immunotherapy × Clear all

Brain Neoplasms, Glioblastoma

NCT02197169 2018-07-16

TARGET-I

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Nervous System Diseases, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Gliosarcoma

Clinical Trials

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

TARGET-I